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Abstract
Background: The ergotamine tartrate associated with certain categories of drugs can lead to critical ischemia of
the extremities. Discontinuation of taking ergotamine is usually sufficient for the total regression of ischemia, but in
some cases it could be necessary thrombolytic and anticoagulant therapy to avoid amputation.
Case report: A woman of 62 years presented with a severe pain left forearm appeared 10 days ago, with a
worsening trend. The same symptoms appeared after 5 days also in the right forearm. Physical examination
showed the right arm slightly hypothermic, with radial reduced pulse in presence of reduced sensitivity. The left
arm was frankly hypothermic, pulse less on radial and with an ulnar humeral reduced pulse, associated to a
decreased sensitivity and motility.
Clinical history shows a chronic headache for which the patient took a daily basis for years Cafergot suppository
(equivalent to 3.2 mg of ergotamine).
From about ten days had begun therapy with itraconazole for vaginal candidiasis. The Color-Doppler ultrasound
shown arterial thrombosis of the upper limbs (humeral and radial bilateral), with minimal residual flow to the right
and no signal on the humeral and radial left artery.
Results: Angiography revealed progressive reduction in size of the axillary artery and right humeral artery stenosis
with right segmental occlusions and multiple hypertrophic collateral circulations at the elbow joint. At the level of
the right forearm was recognizable only the radial artery, decreased in size. Does not recognize the ulnar,
interosseous artery was thin. To the left showed progressive reduction in size of the distal subclavian and humeral
artery, determined by multiple segmental steno-occlusion with collateral vessels serving only a thin hypotrophic
interosseous artery.
Arteriographic findings were compatible with systemic drug-induced disease. The immediate implementation of
thrombolysis, continued for 26 hours, with heparin in continuous intravenous infusion and subsequent
anticoagulant therapy allowed the gradual disappearance of the symptoms with the reappearance of peripheral
pulses.
Conclusion: Angiography showed regression of vasospasm and the resumption of flow in distal vessels. The
patient had regained sensitivity and motility in the upper limbs and bilaterally radial and ulnar were present.
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A 62 years woman was admitted in our Institute com-
plaining a strong bilateral forearm pain. The pain left
upper limb had appeared 10 days ago and after 5 days
was also presented on the right side.
The history revealed that the patient was suffering
from migraine with aura and therefore she took Cafer-
got
® (ergotamine) for 5-6 years, 2-4 mg/day. The
patient, with these doses of ergotamine, could control
the headaches that immediately recurred in case of drug
withdrawal.
Moreover, 10 days before she had started taking 4
tablets per day of Sporanox
® (itraconazole) for a vaginal
candidiasis.
The pain was first discontinuous, associated with
effort, and only after become continuous. Physical exam-
ination showed the right arm hypothermic, with reduced
radial pulse, in the absence of motility deficiency and
loss of sensation.
The left arm was frankly hypothermic in the absence
of radial and ulnar humeral loss of pulse.
At the CW-Doppler control: absence of signal in the
left radial and ulnar artery and demodulated signal at
humeral artery; on the right, demodulated signal at the
radial and ulnar arteries.
After a Color-Doppler ultrasound of the upper limbs,
which showed bilateral humerus thrombosis with mini-
mal residual flow on the right radial artery and no signal
on the left radial artery, the patient was subjected to
emergency upper limb angiography for possible throm-
bolytic therapy.
Under local anesthesia, a right femoral approach was
performed through a 4F introducer sheath. Angiography
revealed a progressive reduction of caliber at the right
axillary artery with a steno-occlusions of the right hum-
eral artery and multiple segmental hypertrophic collat-
eral circulation in the elbow joint. At the level of the
right forearm was recognizable only the radial artery,
decreased in size. To the left, showed progressive reduc-
tion in size of the distal subclavian and humeral arteries,
determined by multiple segmental steno-occlusion with
collateral hypotrophic vessels that belatedly revascular-
ized only a thin interosseous artery (Figure 1).
The arteriographic findings were compatible with sys-
temic drug induced disease: ergotamine therapy was
suddently suspended.
The thrombolytic treatment was performed through a
4F catheter with the tip placed at the origin of the bra-
chial artery: after a 60.000 urokinase U.I injection, a
slow intra-arterial infusion of urokinase and heparin
during the following hours was performed.
At the end of the procedure, after the administration
of about 1.300.000 U.I of urokinase, patency of the
brachial and ulnar artery was re-established, obtaining a
good perfusion of the hand; however, a concentric ste-
nosis was still detectable in the distal brachial artery and
in the ulnar and radial arteries. The immediate imple-
mentation of thrombolysis, continued for 26 hours,
keeping the patient anticoagulation with heparin infu-
sion pump (15.000 IU/24 h, to maintain a PTT of 50-55
sec) led to the gradual disappearance of the symptoms
of patients with recurrence of the peripheral pulses.
Serial angiograms during the procedure shew a gra-
dual thrombolytic recanalization of the artery occluded,
in the presence of angiographic signs of concentric wall
thickening of vasculitic nature.
The final angiographic control shew regression of
vasospasm and the resumption of flow in distal vessels
(Figure 2).
Figure 1 First angiography, showing the right arm with only
the radial artery, decreased in size.
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imbricate with oral anticoagulant therapy (Coumadin
®,
maintaining an INR between 2.0 and 3.0), and supported
for 12 days with intravenous prostaglandin treatment
(Prostavasin
® 20 mg/day).
To complete diagnosis, were sought: anticardiolipin,
anti-beta 2 GPIa IgG IgM to exclude immunological
genesis (all doses appeared to be normal); genetic testing
(factors II and V Leiden) and homocysteine assay for
exclude metabolic diseases with genetic etiology (all
doses appeared to be normal); aortic arch arteriography
allowed to exclude a primary disease like Takayasu
arthritis type. Moreover, we proposed to test antithrom-
bin, protein C/S deficiency and the prothrombin muta-
tion (20210A) and all results were negative.
During hospitalization, three days after ergotamine
discontinuation, the patient presented a strong trend to
worsening headache accompanied by nausea and vomit-
ing that required an implemented treatment with benzo-
diazepines (10 drops of Valium three times daily),
inhibitors of re-uptake of serotonin (Citalopram 10 mg
daily) and an associated steroid (Bentelan) in case of
resistance.
The patient was discharged completely asymptomatic
after two weeks of hospitalization. At two weeks, three
and six months the patient was in subjective well-being,
in absence of motility and sensitivity deficiency. Radial
and ulnar pulses were present bilaterally and a Color-
Doppler ultrasound showed a normal blood supply of
the upper limbs. Even the patient’s headache was con-
trolled by the new implemented therapy after ergot
discontinuation.
Discussion
T h eE r g o t a m i n ei sa na l k a l o i dp r o d u c e db yaf u n g u s ,
Claviceps purpurea [1], described in the history of epi-
demics caused by ingestion of food contaminated with
this fungus [2] and subsequently used to treat migraine,
for its activation of the sympathetic system [3,4].
Ergotamine induced ischemiai sr a r eb u tp o t e n t i a l l y
serious complications may lead through two mechan-
isms: vasospasm and thrombosis. Toxicity arises from
chronic therapeutic doses, acute ingestion of excessive
doses of the drug and acute ingestion of therapeutic
doses in patients with hypersensitivity.
T h el i t e r a t u r es h o w sas u r p r i s i n g l yl o wn u m b e ro f
clinical cases using angiographic evidence of arterial ste-
nosis showed a rapidly reversible after discontinuation
of ergotamine [5-7].
McKiernan et al reported a case of severe vasospasm
of the lower extremities (and renal artery) induced by
ergotamine tartrate [8].
Martinet et al. used the Duplex ultrasound showing
multiple areas of vasospasm in the lower limbs in a
woman of 38 years who suffered from “chronic
migraine” treated with ergotamine tartrate and resolved
after infusion of sodium nitroprusside and epidural
analgesia [9].
Figure 2 Last angiography, after thrombolysis, with a normal
vascularisation of the right forearm.
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load the lower extremities in a patient taking Cafergot
for migraine headaches [10].
Regarding the treatment of limb ischemia upper and
lower drug discontinuation is certainly the first proce-
dure to be implemented, but not always sufficient to
reverse the disease in place.
In severe forms of ischemia refractory to therapy sur-
gical sympathectomy with balloon dilatation or arterial
dilation can be effective, however the patient manage-
ment depends on clinical and instrumental monitoring
of vasospasm, especially in cases of advanced ischemia.
B o n g a r da n dB o u n a m e a u xi n f u s e ds o d i u mn i t r o p r u s -
side in 6 patients with severe acute lower limb ischemia
due to ergotamine tartrate or dihydroergotamine
recruitment, the vasospasm was relieved within 48 hours
in all patients except one [11].
Thrombolysis was effective in the patient described by
D’A m o r ee ta l .[ 1 0 ] .I nr e f r a c t o r yc a s e s ,t h eP T Ah a s
been proposed.
The ergotamine discontinuation with the infusion of
nitroprusside or nitroglycerin appears to solve the pro-
blem in most cases [12].
In our case the patient took ergotamine chronically for
about three years without any reported problems, the
addition of an antifungal (itraconazole) has caused the
artery vasospasm and thrombosis of the upper limbs.
The interaction of erythromycin and ergotamine at low
doses can cause ischemia of the lower extremities [13].
Similarly, taking 3 mg ergotamine over 5 days led to a
severe vasospasm requiring amputation transmetatarsale
when it was administered to a patient treated with the
drug anti-HIV ritonavir [14]. Recently, Baldwin et al.
described a case of ergotamine toxicity in an HIV-posi-
tive patients treated with protease inhibitors [15].
In our case, we decided to start thrombolytic therapy
continued for 26 hours maintaining the patient on antic-
oagulation with heparin infusion (maintaining a PTT of
5 0 - 5 5s e c )f o r3d a y s ,t h e no v e r l a p p e dw i t ha no r a l
anticoagulant therapy. At the same time a vasoactive
therapy was also carried out for 15 days. This attitude
has led to the gradual resolution of the ischemic and
the clinical point of view with the reappearance of per-
ipheral pulses, both in terms of radiological with com-
plete resolution of vasospasm and thrombotic process.
In conclusion in the literature has not documented any
cases of ischemia with the combination of ergotamine
and itraconazole, should we believe an aggressive thera-
peutic approach in cases of significant clinical impair-
ment and instrumental. We believe that in cases of
vasospasm associated with arterial thrombosis thrombo-
lytic treatment, when necessary, PTA and vaso-active
therapy provides an excellent immediate result avoiding
prolonged ischemic pain related complications.
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